TickerFacts.

Sight Sciences, Inc. (SGHT): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$36.61M
Year ended 2025-12-31
-$27.46M
Trailing 12 months to 2026-06-30
2023-12-31: -$56.66M2024-12-31: -$49.82M2025-12-31: -$36.61M-$36.61M
2023-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$36.61Mn/m2026-03-04, From 2025-01-01
2024-12-31-$49.82Mn/m2026-03-04, From 2024-01-01
2023-12-31-$56.66Mn/a2025-03-07, From 2023-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Sight Sciences, Inc. (SGHT)2025-12-31-$36.61Mn/m
PRO DEX Inc (PDEX)2026-06-30$14.38M+20.6%
AVITA Medical, Inc. (RCEL)2025-12-31-$40.19Mn/m
Iradimed Corp (IRMD)2025-12-31$27.31M+19.9%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30-$126.03Mn/m
Anika Therapeutics, Inc. (ANIK)2025-12-31-$5.68Mn/m
Apyx Medical Corp (APYX)2025-12-31-$5.79Mn/m
Orasure Technologies Inc (OSUR)2025-12-31-$61.78Mn/m
Carlsmed, Inc. (CARL)2025-12-31-$30.29Mn/m

Compare SGHT, PDEX, RCEL, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗